Drug interactions between voriconazole, darunavir/ritonavir and tenofovir/emtricitabine in an HIV-infected patient treated for Aspergillus candidus lung abscess
Authors:
- 1 September 2014
- journal article
- case report
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 26 (9) , 672-675
Abstract
We report an unusual case of pulmonary aspergillosis in a patient with AIDS and we demonstrated the drug-drug interactions between voriconazole, darunavir/ritonavir and tenofovir/emtricitabine. The combination darunavir-ritonavir-voriconazole should be avoided.Keywords
This publication has 8 references indexed in Scilit:
- Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumoniaAIDS, 2012
- Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy VolunteersThe Journal of Clinical Pharmacology, 2012
- Aspergillose pulmonaire et infection à VIH : à propos de deux casRevue de Pneumologie Clinique, 2012
- Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumoniaAIDS, 2011
- Primary aspergilloma and subacute invasive aspergillosis in two AIDS patientsRevista do Instituto de Medicina Tropical de São Paulo, 2009
- Steady-State Pharmacokinetic and Safety Profiles of Voriconazole and Ritonavir in Healthy Male SubjectsAntimicrobial Agents and Chemotherapy, 2007
- Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavirClinical Pharmacology & Therapeutics, 2006
- Chronic necrotizing pulmonary aspergillosis after tuberculosis in an HIV-positive woman: an unusual immune reconstitution phenomenon?AIDS, 2005